Oliver Holger Krämer

33PUBLICATIONS
68CO-AUTHORS
Medical infection agents (incl. prions)Innate immunityHaematological tumoursMedical molecular engineering of nucleic acids and proteinsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Oct 30, 2026
Rapid proteasomal degradation of mutant feline McDonough sarcoma-like tyrosine kinase-3 overcomes inhibitor resistance mechanisms of acute myeloid leukemia cells.

|Sep 02, 2026
Mitochondrial checkpoint for interferon responses in macrophages.

|May 27, 2026
Dual FLT3/MAPK14 Proteolysis-Targeting Chimera (PROTAC) Induces Potent Acute Myeloid Leukemia Cell Death.

|May 15, 2026
The Host Cell Factor Phosphatase-2A Subunit PR130 Restricts Replication of Herpes Simplex Virus Type-1.

|Oct 17, 2025
Identification of a Proteolysis-Targeting-Chimera that Addresses Activated Checkpoint Kinase-1 Reveals its Non-Catalytic Functions in Tumor Cells.

Ramy Ashry, Mohamed Abdelsalam, Julia Hausen

|Sep 08, 2025
News and views: lysine sorbylation enters the expanding universe of posttranslational modifications.

Ramy Ashry, Oliver H Krämer

Pageof 6

Frequent Collaborators

8 joint publications

Wolfgang Sippl

7 joint publications

Oliver H Krämer

7 joint publications

Walburgis Brenner

5 joint publications

Ramy Ashry